These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22521430)
1. Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Fertin M; Bauters A; Pinet F; Bauters C J Cardiol; 2012 Aug; 60(2):93-7. PubMed ID: 22521430 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Fertin M; Hennache B; Hamon M; Ennezat PV; Biausque F; Elkohen M; Nugue O; Tricot O; Lamblin N; Pinet F; Bauters C Am J Cardiol; 2010 Nov; 106(10):1410-6. PubMed ID: 21059429 [TBL] [Abstract][Full Text] [Related]
3. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618 [TBL] [Abstract][Full Text] [Related]
4. Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study). Lamblin N; Bauters A; Fertin M; de Groote P; Pinet F; Bauters C Eur J Heart Fail; 2011 Dec; 13(12):1314-22. PubMed ID: 21996026 [TBL] [Abstract][Full Text] [Related]
5. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. Bauters C; Kumarswamy R; Holzmann A; Bretthauer J; Anker SD; Pinet F; Thum T Int J Cardiol; 2013 Oct; 168(3):1837-40. PubMed ID: 23347612 [TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study. Eschalier R; Fertin M; Fay R; Bauters C; Zannad F; Pinet F; Rossignol P Circ Heart Fail; 2013 Nov; 6(6):1199-205. PubMed ID: 23983248 [TBL] [Abstract][Full Text] [Related]
7. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C; Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315 [TBL] [Abstract][Full Text] [Related]
9. Value of brain natriuretic peptide after acute myocardial infarction. Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723 [TBL] [Abstract][Full Text] [Related]
10. Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction. Devaux Y; Vausort M; Azuaje F; Vaillant M; Lair ML; Gayat E; Lassus J; Ng LL; Kelly D; Wagner DR; Squire IB J Card Fail; 2012 Apr; 18(4):330-7. PubMed ID: 22464775 [TBL] [Abstract][Full Text] [Related]
11. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178 [TBL] [Abstract][Full Text] [Related]
12. Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. White M; Rouleau JL; Hall C; Arnold M; Harel F; Sirois P; Greaves S; Solomon S; Ajani U; Glynn R; Hennekens C; Pfeffer M Am Heart J; 2001 Dec; 142(6):1056-64. PubMed ID: 11717612 [TBL] [Abstract][Full Text] [Related]
13. Relationship between circulating soluble Fas ligand and preexisting left ventricular hypertrophy in the setting of left ventricular remodeling after acute myocardial infarction. Esen O; Ağuş HZ; Güler GB; Açar G; Avci A; Güler E; Karaca O; Geçmen C; Bulut M; Emiroğlu Y; Esen AM Coron Artery Dis; 2011 Aug; 22(5):294-8. PubMed ID: 21422918 [TBL] [Abstract][Full Text] [Related]
14. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643 [TBL] [Abstract][Full Text] [Related]
15. Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus. Lamblin N; Fertin M; de Groote P; Bauters C J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):353-9. PubMed ID: 22498999 [TBL] [Abstract][Full Text] [Related]